Axsome Therapeutics
AXSM
AXSM
167 hedge funds and large institutions have $704M invested in Axsome Therapeutics in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 171 → 167 (-4)
12% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 57
14% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 29
Holders
167
Holding in Top 10
1
Calls
$141M
Puts
$49.9M
Top Buyers
| 1 | +$29.3M | |
| 2 | +$11.4M | |
| 3 | +$8.13M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.62M |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$4.35M |
Top Sellers
| 1 | -$30.7M | |
| 2 | -$10.7M | |
| 3 | -$10.2M | |
| 4 |
Morgan Stanley
New York
|
-$7.14M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$3.82M |